ARCT · Arcturus Therapeutics Holdings Inc
United States · RS rating 68 · As of 2026-11-03
| Price | 9.54 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 68 / 9 / 95 / 47 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 23 / 29 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -110.2% |
| Sales growth Q/Q | -78.2% |
| Distance from 52-week high | +43.6% |
| Market cap (USD) | $240.7M |